|
1
|
Tsochatzis EA, Meyer T and Burroughs AK:
Hepatocellular carcinoma. N Engl J Med. 366:92–93. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zimmerman MA, Ghobrial RM, Tong MJ, Hiatt
JR, Cameron AM, Hong J and Busuttil RW: Recurrence of
hepatocellular carcinoma following liver transplantation: A review
of preoperative and postoperative prognostic indicators. Arch Surg.
143:182–188. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ludwig JA and Weinstein JN: Biomarkers in
cancer staging, prognosis and treatment selection. Nat Rev Cancer.
5:845–856. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kung JT, Colognori D and Lee JT: Long
noncoding RNAs: Past, present, and future. Genetics. 193:651–669.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang J, Xie G, Singh M, Ghanbarian AT,
Raskó T, Szvetnik A, Cai H, Besser D, Prigione A, Fuchs NV, et al:
Primate-specific endogenous retrovirus-driven transcription defines
naive-like stem cells. Nature. 516:405–409. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Wang Y, Li J, Zhang Y, Yin H and
Han B: CRNDE, a long-noncoding RNA, promotes glioma cell growth and
invasion through mTOR signaling. Cancer Lett. 367:122–128. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Leveille N, Melo CA, Rooijers K,
Díaz-Lagares A, Melo SA, Korkmaz G, Lopes R, Moqadam Akbari F, Maia
AR, Wijchers PJ, et al: Genome-wide profiling of p53-regulated
enhancer RNAs uncovers a subset of enhancers controlled by a
lncRNA. Nat Commun. 6:65202015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qiu JJ, Wang Y, Ding JX, Jin HY, Yang G
and Hua KQ: The long non-coding RNA HOTAIR promotes the
proliferation of serous ovarian cancer cells through the regulation
of cell cycle arrest and apoptosis. Exp Cell Res. 333:238–248.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cui M, Xiao Z, Wang Y, Zheng M, Song T,
Cai X, Sun B, Ye L and Zhang X: Long noncoding RNA HULC modulates
abnormal lipid metabolism in hepatoma cells through an
miR-9-mediated RXRA signaling pathway. Cancer Res. 75:846–857.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang J, Jiang R, Deng L, Zhang X, Wang K
and Sun B: Circulation long non-coding RNAs act as biomarkers for
predicting tumorigenesis and metastasis in hepatocellular
carcinoma. Oncotarget. 6:4505–4515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu D, Yang F, Yuan JH, Zhang L, Bi HS,
Zhou CC, Liu F, Wang F and Sun SH: Long noncoding RNAs associated
with liver regeneration 1 accelerates hepatocyte proliferation
during liver regeneration by activating Wnt/β-catenin signaling.
Hepatology. 58:739–751. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang F, Yuan JH, Wang SB, Yang F, Yuan SX,
Ye C, Yang N, Zhou WP, Li WL, Li W and Sun SH: Oncofetal long
noncoding RNA PVT1 promotes proliferation and stem cell-like
property of hepatocellular carcinoma cells by stabilizing NOP2.
Hepatology. 60:1278–1290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lechel A and Gougelet A: Early HCC
treatment: A future strategy against interferon/miR-484 axis to
revert precancerous lesions? Gut. 65:1073–1074. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iguchi T, Uchi R, Nambara S, Saito T,
Komatsu H, Hirata H, Ueda M, Sakimura S, Takano Y, Kurashige J, et
al: A long noncoding RNA, lncRNA-ATB, is involved in the
progression and prognosis of colorectal cancer. Anticancer Res.
35:1385–1388. 2015.PubMed/NCBI
|
|
20
|
Qiu JJ, Lin YY, Ding JX, Feng WW, Jin HY
and Hua KQ: Long non-coding RNA ANRIL predicts poor prognosis and
promotes invasion/metastasis in serous ovarian cancer. Int J Oncol.
46:2497–2505. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yue B, Qiu S, Zhao S, Liu C, Zhang D, Yu
F, Peng Z and Yan D: LncRNA-ATB mediated E-cadherin repression
promotes the progression of colon cancer and predicts poor
prognosis. J Gastroenterol Hepatol. 31:595–603. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo F, Sun B, Li H, Xu Y, Liu Y, Liu X, Lu
L, Li J, Wang Q, Wei S, et al: A MALAT1/HIF-2α feedback loop
contributes to arsenite carcinogenesis. Oncotarget. 7:5769–5787.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Panzitt K, Tschernatsch MM, Guelly C,
Moustafa T, Stradner M, Strohmaier HM, Buck CR, Denk H, Schroeder
R, Trauner M and Zatloukal K: Characterization of HULC, a novel
gene with striking up-regulation in hepatocellular carcinoma, as
noncoding RNA. Gastroenterology. 132:330–342. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ohrnberger S, Thavamani A, Braeuning A,
Lipka DB, Kirilov M, Geffers R, Autenrieth SE, Römer M, Zell A,
Bonin M, et al: Dysregulated serum response factor triggers
formation of hepatocellular carcinoma. Hepatology. 61:979–989.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li J, Chen Z, Tian L, Zhou C, He MY, Gao
Y, Wang S, Zhou F, Shi S, Feng X, et al: LncRNA profile study
reveals a three-lncRNA signature associated with the survival of
patients with oesophageal squamous cell carcinoma. Gut.
63:1700–1710. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thum T: Noncoding RNAs and myocardial
fibrosis. Nat Rev Cardiol. 11:655–663. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang S, Chen S, Yang G, Gu F, Li M, Zhong
B, Hu J, Hoffman A and Chen M: Long noncoding RNA HOTAIR as an
independent prognostic marker in cancer: A meta-analysis. PLoS One.
9:e1055382014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Carr BI, Guerra V, Giannini EG, Farinati
F, Ciccarese F, Rapaccini GL, Di Marco M, Benvegnù L, Zoli M,
Borzio F, et al: Significance of platelet and AFP levels and liver
function parameters for HCC size and survival. Int J Biol Markers.
29:e215–e223. 2014.PubMed/NCBI
|
|
29
|
Dwyer JP, Hosking P and Lubel J: Multiple
liver lesions in a patient with positive hepatitis C serology and
elevated AFP: Is it HCC? Gastroenterology. 147:e12–e13. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z,
Deng X, Chen H, Shen B, Peng C, et al: Upregulation of long
noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor
prognosis in hepatocellular carcinoma. Oncogene. 35:1575–1584.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z,
Deng X, Chen H, Shen B, Peng C, et al: Amplification of long
noncoding RNA ZFAS1 promotes metastasis in hepatocellular
carcinoma. Cancer Res. 75:3181–3191. 2015. View Article : Google Scholar : PubMed/NCBI
|
